- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nov Meta Pharma Co Ltd (229500)
Nov Meta Pharma Co Ltd stock price live, this page displays KN 229500 stock exchange data. View the 229500 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nov Meta Pharma Co Ltd real time stock price chart below.
What Is the Nov Meta Pharma Co Ltd Stock Price Today?
The Nov Meta Pharma Co Ltd stock price today is 14,700.
What Is the Stock Symbol for Nov Meta Pharma Co Ltd?
The stock symbol for Nov Meta Pharma Co Ltd is ""229500.""
What Stock Exchange Does Nov Meta Pharma Co Ltd Trade On?
Nov Meta Pharma Co Ltd is listed and trades on the KONEX stock exchange.
Is Nov Meta Pharma Co Ltd a Good Stock to Buy?
Determining whether Nov Meta Pharma Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 229500 quote. (ISIN: KR7229500004)
What Is the Nov Meta Pharma Co Ltd Stock Price Today?
The Nov Meta Pharma Co Ltd stock price today is 14,700.
What Is the Stock Symbol for Nov Meta Pharma Co Ltd?
The stock symbol for Nov Meta Pharma Co Ltd is ""229500.""
What Stock Exchange Does Nov Meta Pharma Co Ltd Trade On?
Nov Meta Pharma Co Ltd is listed and trades on the KONEX stock exchange.
Is Nov Meta Pharma Co Ltd a Good Stock to Buy?
Determining whether Nov Meta Pharma Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 229500 quote. (ISIN: KR7229500004)
KONEX
Currency in KRW
14,700
-240(-1.61%)
Delayed Data·
Fair Value
An estimate of a Nov Meta Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14,200
15,000
52 wk Range
4,505
17,890
229500 Scorecard
Full Analysis
Suffers from weak gross profit margins
229500 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Nov Meta Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14,20015,000
52 wk Range
4,50517,890
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
229500 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Nov Meta Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a poor free cash flow yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Nov Meta Pharma Co Ltd Company Profile
NovMetaPharma Co., Ltd. engages in the development and sale of drugs to treat metabolic diseases in South Korea. The company is developing NovDB2, a type 2 diabetes medication; NovOB, an anti-obesity medication; NovRD, a chronic kidney disease medication; NovFS, a fibrosis medication; and NovRF, a retroperitoneal fibrosis medication. It also develops drugs for inflammatory bowel; viral; vascular; bone loss; bone loss; cognitive impairment; Alzheimer’s; acute pancreatitis; degenerative brain; and liver cancer diseases, as well as cytokine inhibitor and exercise performance enhancement products. The company was formerly known as PNC MetaPharm Co., Ltd. and changed its name to NovMetaPharma Co., Ltd. in May 2015. NovMetaPharma Co., Ltd. was founded in 2010 and is headquartered in Seoul, South Korea.
Compare 229500 to Peers and Sector
Metrics to compare | 229500 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship229500PeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −4.4x | −0.5x | |
PEG Ratio | 0.00 | 0.03 | 0.00 | |
Price/Book | 0.0x | 1.1x | 2.6x | |
Price / LTM Sales | 0.0x | 0.9x | 3.3x | |
Upside (Analyst Target) | 0.0% | 0.0% | 43.3% | |
Fair Value Upside | Unlock | 11.0% | 6.9% | Unlock |
FAQ
What Stock Exchange Does Nov Meta Pharma Trade On?
Nov Meta Pharma is listed and trades on the Korea New Exchange stock exchange.
What Is the Stock Symbol for Nov Meta Pharma?
The stock symbol for Nov Meta Pharma is "229500."
What Is the Nov Meta Pharma Market Cap?
As of today, Nov Meta Pharma market cap is 181.15B.
What Is Nov Meta Pharma's Earnings Per Share (TTM)?
The Nov Meta Pharma EPS (TTM) is 0.00.
From a Technical Analysis Perspective, Is 229500 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Nov Meta Pharma Stock Split?
Nov Meta Pharma has split 1 times.
How Many Employees Does Nov Meta Pharma Have?
Nov Meta Pharma has 0 employees.
What is the current trading status of Nov Meta Pharma (229500)?
As of 11 Aug 2025, Nov Meta Pharma (229500) is trading at a price of 14,700.00, with a previous close of 14,940.00. The stock has fluctuated within a day range of 14,200.00 to 15,000.00, while its 52-week range spans from 4,505.00 to 17,890.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.